$47.30
+4.33%Nov 4, 2026, 15:12 UTC
China’s Ministry of Commerce held a roundtable in Shanghai with more than 100 multinational companies and foreign business associations attending.
Source:Nov 3, 2026, 17:01 UTC
RECURSION PHARMACEUTICALS, INC. reported third-quarter revenue up 258.5%, with results boosted by a $10 million milestone payment from Sanofi.
Source:Oct 30, 2026, 15:06 UTC
Sanofi shares rose.
Source:Oct 30, 2026, 15:06 UTC
Sanofi reported third-quarter earnings and sales above estimates, with Dupixent driving growth.
Source:Oct 29, 2026, 13:37 UTC
Sanofi initiated a Phase 3 influenza-COVID-19 combination vaccine trial in Europe using NOVAVAX INC's Nuvaxovid, triggering a $125 million milestone payment to NOVAVAX INC.
Source:Oct 26, 2026, 10:30 UTC
Sanofi signed a research agreement with Khalifa University to study genetic factors associated with asthma and chronic obstructive pulmonary disease using UAE health and genomic data.
Source:Oct 21, 2026, 08:00 UTC
At a German government economic summit, companies pledged around €230 billion in investments, according to Chancellor Friedrich Merz.
Source:Oct 20, 2026, 16:00 UTC
Apidra insulin is currently unavailable in Pakistan because of international supply constraints, while other insulin products remain accessible, according to a health ministry spokesperson.
Source:Oct 20, 2026, 13:10 UTC
Eleven Therapeutics Ltd. announced a worldwide strategic collaboration and licensing agreement with Sanofi to develop and commercialize extended-exposure therapeutics.
Source:Oct 15, 2026, 23:59 UTC
Sanofi kicked off a collaboration with RECURSION PHARMACEUTICALS, INC. to develop drug molecules.
Source:Oct 15, 2026, 23:59 UTC
RECURSION PHARMACEUTICALS, INC. shares rose 11.23%.
Source:Oct 15, 2026, 16:02 UTC
Sanofi and the pan-Canadian Pharmaceutical Alliance signed a letter of intent to support patient access to Dupixent through Canadian public drug plans for four indications in dermatology and respiratory care.
Source:Oct 15, 2026, 12:51 UTC
Recursion Pharmaceuticals reported that Sanofi exercised an option on a development candidate under their research collaboration, triggering a $10 million milestone payment.
Source:Oct 14, 2026, 08:26 UTC
The European Commission accepted Sanofi’s concessions to settle an antitrust probe into its marketing messages about a rival flu shot.
Source:Oct 6, 2026, 12:03 UTC
Regeneron Pharmaceuticals agreed to dismiss its lawsuit against Sanofi over access to material information on Dupixent commercialization and audit rights under the Antibody License and Collaboration Agreement.
Oct 5, 2026, 17:59 UTC
Judge Zahid N. Quraishi of the U.S. District Court for the District of New Jersey held the initial case management conference in the federal multidistrict litigation alleging that Dupixent (dupilumab) can cause, accelerate or unmask cutaneous T-cell lymphoma (CTCL).
Source:Oct 3, 2026, 14:45 UTC
A Russian air strike on Friday, Oct. 2 set fire to a pharmaceutical storage warehouse belonging to Ukrainian drug distributor Venta near Kyiv, destroying inventories of medicines made by Bayer, Sanofi, Pfizer, Teva, Darnytsia and Farmak.
Source:Sep 28, 2026, 22:00 UTC
The U.S. CDC reinstated its earlier, broader COVID-19 vaccine recommendations, including for children and younger adults, in compliance with a March 2026 court stay, even though some uses are off-label relative to FDA approvals.
Source:Sep 28, 2026, 16:00 UTC
Morningstar moved Sanofi, LPL Financial Holdings, Edison International, SBA Communications, and Stellantis to 5-star ratings from 4 stars after their share prices fell over the past week.
Source:Sep 25, 2026, 21:34 UTC
Health Canada announced that Sanofi-Aventis Canada is recalling insulin pens and insulin cartridges that may have been frozen during transport.
Sep 25, 2026, 07:00 UTC
The Swiss Re Foundation, with partners Digital Connected Care Coalition, AXA EssentiALL, Sanofi Global Health Unit Impact Fund, and Philips Foundation, opened applications for the 10th edition of its Entrepreneurs for Resilience 2027 programme, offering US$1.3 million in funding and support to social enterprises delivering affordable primary healthcare in low- and middle-income countries.
Source:Sep 22, 2026, 23:59 UTC
Florida Attorney General James Uthmeier announced a lawsuit in Tampa against insulin manufacturers Eli Lilly, Novo Nordisk and Sanofi, pharmacy benefit managers CVS Caremark, Express Scripts and Optum Rx, and rebate aggregators Zinc, Ascent and Emisar, alleging price-fixing, anti-competitive behavior and deceptive trade practices in insulin and diabetes-related drugs.
Sep 22, 2026, 01:10 UTC
On September 21, Yifan Pharmaceutical and South Korea's Boryung Pharmaceutical announced a partnership under which Yifan Pharmaceutical obtained exclusive general agency rights for Taxotere (docetaxel injection) in China, handling promotion, distribution and commercialization there.
Page 1Next →